Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03257267
Title Study of REGN2810 in Adults With Cervical Cancer
Recruitment Completed
Gender female
Phase Phase III
Variant Requirements No
Sponsors Regeneron Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | ITA | GRC | GBR | ESP | CAN | BRA | BEL | AUS


No variant requirements are available.